Health & Biotech
Check out the latest Cannabis news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
Health & Biotech
MGC Pharma attracts $5m grant for its Malta-based production facility
Health & Biotech
ECS Botanics raises $4 million to fund medicinal cannabis facility in Tasmania
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Althea: TGA pot decision will benefit its flagship CBD product
Health & Biotech
US study shows IHL’s CBD treatment is effective in treating concussion, shares jump again
Health & Biotech
Creso Pharma’s CBD medicines will be available prescription free in Australia
Experts
MoneyTalks: Peak Asset’s looking at these renewables, cannabis and gold plays in 2021
Health & Biotech
TGA makes interim decision on CBD products official but cannabis stocks actually dropped
Food & Agriculture
Roots Sustainable Agriculture gaining ground in Israeli cannabis sector
Health & Biotech
MGC Pharmaceuticals confirms Phase II trial success for anti-inflammatory COVID treatment
Health & Biotech
Zelira shares soar after expanding US medical pot distribution
News
Weekly ASX small cap wrap: Who are the cup winners and wooden spoon recipients?
Health & Biotech
Creso Pharma signs deal with natural lifestyle brand supplier Martin & Pleasance
Food & Agriculture
Roots Sustainable Agriculture making inroads into US cannabis industry
News
The ‘basket of stocks’ approach is helping Australian investors hunt market thematics
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
Creso Pharma subsidiary expands into Canada’s biggest recreational market
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
ASX pot stocks keep climbing after US House vote; now up 52 per cent in a month
Health & Biotech
Creso Pharma hails US House vote to decriminalise cannabis at federal level
Health & Biotech
Creso Pharma’s secret weapon is a cannabis veteran who knows what cannabis enthusiasts want
News
Weekly ASX small cap wrap: Have we seen the end of this happy couple?
Health & Biotech
Lab tests confirm neuro-protective potency of Neurotech’s unique strains of cannabis
Health & Biotech
Creso Pharma seeks to capitalise on European court ruling on CBD – ‘not narcotic’
Health & Biotech
Down-scheduling of CBD would unlock a huge opportunity for Creso Pharma
Stockhead TV
Why Australia’s medicinal cannabis has the leading edge
Health & Biotech
StockDoc Podcast: Biden win has medicinal cannabis sector on high, EXL perfectly placed
Health & Biotech
Incannex says cannabidiol-hydroxychloroquine cocktail shows promise in new animal study
Health & Biotech
MGC Pharma expands network in Australia with clinics deal
Health & Biotech
MGC Pharma achieves success in brain cancer treatment trial
Health & Biotech
Australia’s cannabis sector can reach further highs in 2021 – here’s how it’ll happen
Health & Biotech
Inncanex’s anti-inflammatory and COVID-19 drug candidate showing promise in pre-clinical studies
Health & Biotech
New Zealand looks to have rejected legal recreational marijuana
Private-i
Montu beats crowdfunding records with cannabis equity raising
Health & Biotech
Aurora Cannabis sells its $13m stake in Aussie pot stock Cann Group
Health & Biotech
Creso Pharma has now taken $630,000 in orders from South Africa for cannabis lozenges
Health & Biotech
MGC Pharma ships first Mercury Pharma THC products to Brazil
News
10 at 10: These ASX stocks are looking ripe this morning
Health & Biotech
Creso Pharma gains momentum with another big cannabis order in Nova Scotia
Health & Biotech
Incannex Healthcare books record CBD sales in Q3
Health & Biotech
Canopy Growth Founder joins Creso Pharma
IPO Watch
2018 ASX IPOs are doing much better two years on
Health & Biotech
ECS’ hemp seed oil is proving to be a better source of omega 3
News
Rise and Shine: What you need to know before the ASX opens
News
Aussie regulator raps cannabis companies over their reggie weed
Health & Biotech
Health Kick Podcast: Investors still high on Incannex cannabinoid pivot and COVID-19 treatment news
Health & Biotech
Creso Pharma’s Canadian subsidiary receives $189,000 recreational cannabis order
Load More
